Literature DB >> 1365527

Lessons from Leishmania: a model for investigations of CD4+ subset differentiation.

S L Reiner1, R M Locksley.   

Abstract

Infection of inbred mice with Leishmania major remains the best model of human infection with visceralizing Leishmania that cause kala-azar. Immunologic investigations have correlated the outcome of disease with expansion of different subsets of CD4+ cells, designated Th1 and Th2. Although the capacity of fixed effector Th1 and Th2 populations to mediate the diverse outcomes of disease through the release of soluble cytokines, particularly IFN-gamma and IL-4, has been demonstrated, the mechanisms by which these subsets become established during infection have not been delineated. This review focuses on known features of CD4+ differentiation using other experimental models, and proposes that genetic susceptibility to Leishmania can occur if the host has a Th2 precursor cell in the memory configuration prior to the time of exposure to organisms, perhaps in response to cross-reactive self-peptides. The hypothesis can explain a number of puzzling observations in both murine and human disease due to these organisms and makes several predictions amenable to experimental testing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365527

Source DB:  PubMed          Journal:  Infect Agents Dis        ISSN: 1056-2044


  6 in total

1.  Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring.

Authors:  W C Van Voorhis; L K Barrett; Y T Sweeney; C C Kuo; D L Patton
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis.

Authors:  D M Isaza; M Restrepo; W Mosca
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.

Authors:  L Romani; P Puccetti; A Mencacci; R Spaccapelo; E Cenci; L Tonnetti; F Bistoni
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

4.  Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.

Authors:  J A Kurtzhals; A S Hey; A Jardim; M Kemp; K U Schaefer; E O Odera; C B Christensen; J I Githure; R W Olafson; T G Theander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

5.  A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis.

Authors:  Connor Carson; Maria Antoniou; Maria Begoña Ruiz-Argüello; Antonio Alcami; Vasiliki Christodoulou; Ippokratis Messaritakis; Jenefer M Blackwell; Orin Courtenay
Journal:  Vaccine       Date:  2008-12-16       Impact factor: 3.641

Review 6.  Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.

Authors:  Sergio Coutinho Furtado de Mendonça; Léa Cysne-Finkelstein; Denise Cristina de Souza Matos
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.